CALIFORNIA RESOURCES CORP (CRC)       43.16  -4.67 (-9.76%)

43.16  -4.67 (-9.76%)

US13057Q3056 - Common Stock - After market: 43.16 0 (0%)


Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CRC. CRC was compared to 387 industry peers in the Oil, Gas & Consumable Fuels industry. CRC has a great profitability rating, but there are some minor concerns on its financial health. CRC is not valued too expensively and it also shows a decent growth rate.




Profitability

Profitability Rating

8

CRC's Return On Assets of 28.98% is amongst the best returns of the industry. CRC outperforms 87% of its industry peers. The industry average Return On Assets is 12.18%.
CRC has a Return On Equity of 62.26%. This is amongst the best returns in the industry. The industry average is 25.59%. CRC outperforms 87% of its industry peers.

CRC has a Profit Margin of 43.44%. This is better than the industry average of 25.58%.
CRC has a good Piotroski-F score of 7.00. This indicates a good health and good profitability for CRC.
VS Industry

ROA (28.98%) VS Industry: 87% outperformed.

-40.60
1,189.87

ROE (62.26%) VS Industry: 87% outperformed.

0.24
5,310.48

Profit Margin (43.44%) VS Industry: 77% outperformed.

0.07
268.29

Valuation

Valuation Rating

5

With a Price/Earnings Ratio of 7.39, the valuation of CRC can be described as very cheap.
With a Forward Price/Earnings Ratio of 5.81, the valuation of CRC can be described as cheap.
When comparing the Enterprise Value to EBITDA ratio of CRC to the average industry ratio of 4.25, CRC is valued rather cheaply.
Compared to an average industry Price/Earning Ratio of 6.75, CRC is valued in line with its industry peers.

With a price book ratio of 1.71, CRC is valued correctly.
Compared to an average industry price book ratio of 1.63, CRC is valued in line with its industry peers.
The high PEG Ratio, which compensates the Price/Earnings for growth, indicates CRC does not grow enough to justify the current Price/Earnings ratio.
VS Industry

Price/Earnings (7.39) VS Industry: 45% outperformed.

1,231.25
0.07

Price/Book (1.71) VS Industry: 47% outperformed.

3,370.53
0.04

Enterprise Value/ EBITDA (3.29) VS Industry: 66% outperformed.

248.68
0.22

Growth

Growth Rating

5

CRC is expected to show quite a strong growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 12.63% yearly.
When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
The Revenue has grown by 70.89% in the past year. This is a very strong growth!
Measured over the past 5 years, CRC shows a small growth in Earnings Per Share. The EPS has been growing by 1.76% on average per year.

The Revenue has been growing slightly by 4.08% on average over the past 5 years.
CRC is expected to show a small growth in Revenue. In the coming 5 years, the Revenue will grow by 3.28% yearly.
The Revenue growth is stable: in the next 5 years the growth will be about the same than in the last 5 years.
The earnings per share for CRC have decreased strongly by -83.03% in the last year.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS1.76% 70.72% -83.03% -15.84% 10.15% 9.4% 12.63%
Revenue4.08% -14.89% 70.89% 44.1% 13.68% 10.24% 3.28%

Health

Health Rating

4

The Piotroski-F score of CRC is 7.00. This is a strong score and indicates good health and profitability for CRC.
The Current Ratio is in line with the industry averages, which is at 1.10.
The Quick Ratio is in line with the industry averages, which is at 0.94.
The Debt to Equity ratio of CRC is in line with the industry averages.

CRC has an Altman-Z score of 2.54. This is not the best score and indicates that CRC is in the grey zone with still only limited risk for bankruptcy at the moment.
CRC has a Altman-Z score comparable to the industry average, which is at 2.18.
CRC has a Current Ratio of 0.95. This is a bad value and indicates that CRC is not financially healthy enough and could expect problems in meeting its short term obligations.
CRC has a Quick Ratio of 0.95. This is a bad value and indicates that CRC is not financially healthy enough and could expect problems in meeting its short term obligations.
VS Industry

Debt/Equity (0.32) VS Industry: 48% outperformed.

31.33
0.00

Quick Ratio (0.89) VS Industry: 45% outperformed.

0.00
297.28

Current Ratio (0.95) VS Industry: 41% outperformed.

0.00
297.28

Altman-Z (2.54) VS Industry: 56% outperformed.

-283,883.15
1,166.96

Dividend

Dividend Rating

2

CRC has a Yearly Dividend Yield of 2.39%. Purely for dividend investing, there may be better candidates out there.
CRC's Dividend Yield is comparable with the S&P500 average which is at 2.41.

Compared to an average industry Dividend Yield of 5.56, CRC is paying slightly less dividend.
CRC is new to the dividend game and has less than 3 years of track record.
VS Industry

Dividend Yield (2.39%) VS Industry: 22% outperformed.

0.34
64.51

CALIFORNIA RESOURCES CORP43.16

NYSE:CRC (1/27/2023, 7:04:01 PM)-4.67 (-9.76%)

After market: 43.16 0 (0%)

Chartmill FA Rating
GICS Sector Energy
GICS IndustryGroup Energy
GICS Industry Oil, Gas & Consumable Fuels
Earnings (Last) 11-03 2022-11-03/bmo Earnings (Next) 02-22 2023-02-22
Inst Owners 99.16% Inst Owner Change -0.09%
Ins Owners 0.97% Ins Owner Change -0.85%
Market Cap 3.17B Analysts 82.22
Price Target 64.11 (48.54%)

Dividend
Dividend Yield 2.39% Dividend Growth N/A
DP N/A Ex-Date N/A

Surprises & Revisions
EPS beat(2) 1 Avg EPS beat(2) -20.81%
Min EPS beat(2) -43.52% Max EPS beat(2) 1.91%
EPS beat(4) 2 Avg EPS beat(4) -13.04%
Min EPS beat(4) -43.52% Max EPS beat(4) 1.91%
Revenue beat(2) 2 Avg Revenue beat(2) 67.28%
Min Revenue beat(2) 43.18% Max Revenue beat(2) 91.38%
Revenue beat(4) 3 Avg Revenue beat(4) 20.49%
Min Revenue beat(4) -67.67% Max Revenue beat(4) 91.38%
PT rev (1m) -3.3% EPS NQ rev (1m) 0%
EPS NY rev (1m) 0% Revenue NQ rev (1m) 0%
Revenue NY rev (1m) 0%

Valuation
Industry RankSector Rank
PE 7.39
Fwd PE 5.81
P/S 1.19
P/FCF 7.73
P/OCF 4.07
P/B 1.71
P/tB 1.71
EV/EBITDA 3.29
EPS(TTM) 5.84 EY 13.53%
EPS(NY) 7.43 Fwd EY 17.2%
FCF(TTM) 5.58 FCFY 12.93%
OCF(TTM) 10.62 OCFY 24.6%
SpS 36.19 BVpS 25.25
TBVpS 25.25 PEG (NY) N/A
PEG (5Y) 4.2

Profitability
Industry RankSector Rank
ROA 28.98%
ROE 62.26%
ROIC 21.57%
ROICexc 24.44%
ROICexgc 24.44%
OM 31.37%
PM 43.44%
GM 71.12%
ROICexgc(3y) N/A ROICexcg growth 3Y -12.48%
ROICexcg growth 5Y N/A ROICexc(3y) N/A
ROICexc growth 3Y -12.48% ROICexc growth 5Y N/A
OM growth 3Y -23.53% OM growth 5Y N/A
PM growth 3Y 45.69% PM growth 5Y 12.92%
GM growth 3Y -3.72% GM growth 5Y 5.36%
F-Score 7 Asset Turnover 0.67

Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 1.44
Debt/EBITDA 0.57
Cap/Depr 183.17%
Profit Quality 35.5%
Current Ratio 0.95
Quick Ratio 0.89
Altman-Z 2.54
F-Score 7 WACC 12.76%
ROIC/WACC 1.92 Cap/Depr(3y) 66.89%
Cap/Depr(5y) 81.26% Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y -83.03% EPS 3Y 70.72%
EPS 5Y 1.76% EPS growth Q2Q -20.77%
EPS Next Y -15.84% EPS Next 2Y 10.15%
EPS Next 3Y 9.4% EPS Next 5Y 12.63%
Revenue growth 1Y 70.89% Revenue growth 3Y -14.89%
Revenue growth 5Y 4.08% Revenue growth Q2Q 91.33%
Revenue Next Year 44.1% Revenue Next 2Y 13.68%
Revenue Next 3Y 10.24% Revenue Next 5Y 3.28%
EBIT growth 1Y 783.61% EBIT growth 3Y -34.92%
EBIT growth 5Y N/A EBIT Next Year 46.6%
EBIT Next 3Y 21.97% EBIT Next 5Y 19.8%
FCF growth 1Y 130.34% FCF growth 3Y N/A
FCF growth 5Y 53.32% OCF growth 1Y 181.59%
OCF growth 3Y 12.71% OCF growth 5Y 38.39%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA